Welcome to the BiosearchTech Blog
Be the first to hear about our new technologies, discover how our customers are using our products and enhance your research - all in our latest blog posts.

How to select an effective nucleic acid isolation method for human diagnostics
Molecular testing protocols for pathogen detection and diagnosing human diseases require reliable and high-quality isolation of genetic material from diverse sample types. There are many extraction and purification technologies available. Before deciding which isolation method best suits your application, read this blog that walks you through key considerations...
Read moreThe BiosearchTech Blog
AMP conference 2022: Developing a 5-minute point-of-care PCR test
Posted on Wed, Jan 11, 2023 @ 08:15 AM
Topics: Molecular diagnostics, SARS-CoV-2, Disease detection, Human healthcare
Make your diagnostic workflows more adaptable
Posted on Mon, Jun 06, 2022 @ 02:47 PM
Topics: SARS-CoV-2, Nucleic acid extraction, Disease detection, Human healthcare, Applied agrigenomics, General science
Pandemic reflections: Adapting to testing priorities
Posted on Tue, Apr 05, 2022 @ 04:55 PM
Topics: SARS-CoV-2, Human healthcare
Society can’t handle the caveats to each type of COVID-19 test
Posted on Fri, Feb 11, 2022 @ 04:58 PM
Topics: qPCR, SARS-CoV-2, Human healthcare, General science
Pandemic reflections: in the face of SARS-CoV-2 variants, COVID-19 testing remains essential
Posted on Tue, Jan 11, 2022 @ 12:00 PM
Topics: SARS-CoV-2
Pandemic reflections: unprecedented demand drives COVID-19 test developers to get creative
Posted on Tue, Dec 28, 2021 @ 09:30 AM
Topics: SARS-CoV-2
Technical bulletin: Omicron impact on SARS-CoV-2 mutation analysis and investigation
Posted on Thu, Dec 23, 2021 @ 11:45 AM
Topics: Molecular diagnostics, SARS-CoV-2, Human healthcare
Pandemic reflections: the world is short staffed
Posted on Tue, Dec 21, 2021 @ 06:52 PM
Topics: SARS-CoV-2, Human healthcare
Ensuring our diagnostic assays detect the Omicron variant
Posted on Thu, Dec 09, 2021 @ 04:24 PM
Topics: Molecular diagnostics, SARS-CoV-2
Streamlining diagnostic workflows for common respiratory diseases, such as SARS-CoV-2, influenza and RSV
Posted on Tue, Nov 30, 2021 @ 04:29 PM
Topics: Molecular diagnostics, SARS-CoV-2, Disease detection
Technical bulletin: SARS-CoV-2 mutation analysis and investigation
Posted on Thu, Oct 14, 2021 @ 05:01 PM
Topics: Molecular diagnostics, SARS-CoV-2
Can COVID-19 testing be made more sustainable during prolonged uncertainty?
Posted on Mon, Sep 27, 2021 @ 02:36 PM
Topics: Molecular diagnostics, qPCR, SARS-CoV-2, Human healthcare, General science
Tips for early-stage MDx companies launching new tests during COVID-19 times
Posted on Thu, Sep 02, 2021 @ 02:00 PM
Topics: Molecular diagnostics, SARS-CoV-2, Human healthcare
Wastewater surveillance: a critical tool in pandemic management
Posted on Tue, Aug 31, 2021 @ 09:48 AM
Topics: SARS-CoV-2, Human healthcare
Technical bulletin: Emerging SARS-CoV-2 mutations and their effect on the immune response
Posted on Wed, Aug 18, 2021 @ 03:45 PM
Topics: SARS-CoV-2
Genomic surveillance: 3 techniques to detect and characterise SARS-CoV-2 variants
Posted on Wed, May 19, 2021 @ 11:34 AM
Topics: Molecular diagnostics, Genomics, SARS-CoV-2, Human healthcare, General science
How do SARS-CoV-2 variants affect PCR assays for COVID-19 testing?
Posted on Tue, May 04, 2021 @ 11:03 AM
Topics: Molecular diagnostics, SARS-CoV-2, Human healthcare
Building resilience into SARS-CoV-2 testing workflows: considerations for choosing an RNA isolation method
Posted on Wed, Oct 21, 2020 @ 11:00 AM
Topics: Molecular diagnostics, Genomics, SARS-CoV-2, Human healthcare, General science
Pressing COVID-19 testing issues of today and the near future
Posted on Wed, Aug 26, 2020 @ 09:57 AM
Topics: Molecular diagnostics, Genomics, SARS-CoV-2
Sensitivity and accuracy in COVID-19 testing
Posted on Wed, Aug 19, 2020 @ 09:56 AM
Topics: Molecular diagnostics, Genomics, SARS-CoV-2
Scaling up COVID-19 viral testing
Posted on Wed, Aug 12, 2020 @ 09:47 AM
Topics: Molecular diagnostics, Genomics, SARS-CoV-2
Enabling a rapid response to COVID-19 by Honeywell and LGC, Biosearch Technologies
Posted on Wed, Jul 29, 2020 @ 02:40 PM
Topics: Molecular diagnostics, Genomics, qPCR, SARS-CoV-2
Robust supply chains and open testing systems: How our AgBio roots meet the FDA's EUA process to enable solutions to the COVID-19 pandemic
Posted on Tue, May 19, 2020 @ 10:18 AM
Topics: Molecular diagnostics, Genomics, qPCR, SARS-CoV-2
Behind the scenes: How our oligo synthesis team contributes to the reliability of your assays
Posted on Thu, Apr 30, 2020 @ 04:13 PM
Topics: Molecular diagnostics, Oligo synthesis and modifications, Genomics, SARS-CoV-2, Human healthcare, General science
When you don’t need an EUA for SARS-CoV-2 testing
Posted on Fri, Apr 10, 2020 @ 05:00 PM
Topics: Molecular diagnostics, SARS-CoV-2
Addressing COVID-19 together: LGC, Biosearch Technologies and Shanghai Liferiver Biotechnology Co., Ltd.
Posted on Tue, Mar 31, 2020 @ 12:13 PM
Topics: Molecular diagnostics, Oligo synthesis and modifications, Genomics, SARS-CoV-2
What diagnostic test makers and CLIA labs in the US need to know about Emergency Use Authorization (EUA)
Posted on Tue, Mar 24, 2020 @ 01:58 PM
Topics: Molecular diagnostics, Genomics, SARS-CoV-2, Human healthcare, General science
Coronavirus outbreak: Collaboration to meet the challenge
Posted on Mon, Mar 16, 2020 @ 02:30 PM
Topics: Molecular diagnostics, Genomics, SARS-CoV-2